EXMceuticals Provides Bi-Weekly Default Status Report
27 11월 2019 - 7:02AM
EXMceuticals Inc. (CSE:
EXM)
(FSE: A2PAW2) (the
“
Company” or “
EXM”) is providing
this bi-weekly default status report in accordance with National
Policy 12-203 Management Cease Trade Orders (“
NP
12-203”). On October 23, 2019, the Company announced
that, for reasons set out in its news release of October 23, 2019,
the filing of its annual audited financial statements for the year
ended June 30, 2019, the accompanying management’s discussion and
analysis and the related CEO and CFO certifications (collectively,
the “
Annual Filings”) would not be filed by the
prescribed deadline of October 28, 2019.
On October 29, 2019, the British Columbia
Securities Commission, as principal regulator, granted a temporary
management cease trade order (the “MCTO”).
As previously announced, the Company requires additional time to
file its annual financial statements and MD&A for the financial
year ended June 30, 2019 due to this being the first annual
financial statements of the consolidated company following an RTO
and additional time is required to complete the review and
procedures. As a result, the Company concluded that it would
not be in a position to complete the year-end audit within the time
periods required by National Instrument 51-102. The Company
currently anticipates that it will be in a position to file the
Annual Filings on or before December 27, 2019.
Pursuant to NP 12-203, the Company must file
bi-weekly default status reports in the form of further news
releases during the period of the MCTO. The Company reports
that since its news release of October 23, 2019, there have been no
material changes regarding the information contained in that news
release. The Company confirms there have been no failures by
the Company in fulfilling its stated intentions with respect to
satisfying the provisions of the alternative information guidelines
under NP 12-203, and there has not been, nor is there anticipated
to be, any specified default subsequent to the default announced in
the Company’s news release of October 23, 2019. The Company
also confirms that there is no other material information
concerning the affairs of the Company that has not been generally
disclosed as of the date of this news release.
ON BEHALF OF THE BOARD OF DIRECTORS OF
EXMCEUTICALS INC.
Jonathan Summers, Chairman and Chief Executive
Officer
For further information contact: Investor
Relations Email: investors@exmceuticals.com
Media Enquiries:Email:
media@exmceuticals.comEurope - Jane Glover: +44 (0) 203 757
4990 North America - Mélanie Guillemette: +1 819 668
2734
FOR MORE UPDATES ON THE COMPANY
Follow us on Twitter: https://twitter.com/EXMceuticalsFollow us
on LinkedIn: https://www.linkedin.com/company/exmceuticals/
Neither the CSE nor the FSE has approved nor
disapproved the contents of this news release. Neither the
CSE, nor the FSE accepts responsibility for the adequacy or
accuracy of this release.
The information in this news release includes
certain information and statements about management’s view of
future events, expectations, plans and prospects that constitute
forward looking statements. These statements are based upon
assumptions that are subject to risks and uncertainties. Forward
looking statements in this news release include, but are not
limited to, the Company’s intent to file the Annual Filings.
Although the Company believes that the expectations reflected in
forward looking statements are reasonable, it can give no
assurances that the expectations of any forward looking statement
will prove to be correct. Except as required by law, the Company
disclaims any intention and assumes no obligation to update or
revise any forward looking statements to reflect actual results,
whether as a result of new information, future events, changes in
assumptions, changes in factors affecting such forward looking
statements or otherwise.
EXMceuticals (CSE:EXM)
과거 데이터 주식 차트
부터 11월(11) 2024 으로 12월(12) 2024
EXMceuticals (CSE:EXM)
과거 데이터 주식 차트
부터 12월(12) 2023 으로 12월(12) 2024